Scherzer Returns Monday at 42, but His Workload Tells the Real Story
By Justin Erickson ·
Max Scherzer's birthday start against Washington comes with a pitch-count ceiling that suggests the Blue Jays are managing decline, not banking on a vintage performance.
Max Scherzer will make his first appearance since mid-June on Monday, July 28, when the Blue Jays open a series at Washington on his 42nd birthday. Toronto manager John Schneider confirmed the move after Sunday's loss to Boston, noting that Scherzer checked the boxes during a rehab outing in Triple-A Buffalo on Wednesday, July 23—a five-inning, 56-pitch appearance where he struck out seven. The headline is the return. The subtext is constraint.
Scherzer's season has been a catalog of setbacks. He's 1-4 with a 10.23 ERA across six starts, sandwiched around a mid-June IL stint for back spasms that metastasized into thumb issues requiring three cortisone injections. A pitcher who built a Hall-of-Fame resume on durability and competitive obsession is now managing inflammation across multiple body systems—the signature pattern of aging arms running out of recovery windows. Schneider's comment about a "limited pitch count" is the admission buried in optimistic framing. Scherzer won't be stretched out. He'll be used in pieces.
The timing compounds the picture. The Blue Jays have dropped seven of their last ten games since the All-Star break and sit at a vulnerable point in the standings where every rotation start either stabilizes a contending window or accelerates the slide toward sellers. Scherzer was left off the ALDS roster last October after a late-season collapse, then made the ALCS and World Series rosters only to watch Toronto lose to the Dodgers in seven games. He has two rings—2019 with Washington and 2023 with Texas—but both feel increasingly distant. His 3.27 career ERA across 489 games masks how steep the recent decline has been: the 10.23 mark this season isn't a fluke; it's a data point in a trajectory.
For prop bettors, Scherzer's Monday return presents a classic fade scenario. His strikeout line will likely price in either his historical pedigree (222-121 career record carries weight) or his recent catastrophe (10.23 ERA does not). Toronto's management decision—the pitch count, the rehab start, the three-cortisone-shot thumb—tells you which way the market is probably wrong. Take the under on his strikeout prop. At 42, managing back spasms, operating on a limited pitch count against a Nationals lineup that has seen him before, Scherzer is a name with equity but an arm with constraints. The projection floor is lower than the famous surname suggests.
Monday's game also has implications for the Blue Jays' bullpen strain. If Scherzer exits early—which the pitch-count ceiling makes likely—Toronto's relief corps enters a game against a divisional opponent already stretched thin. That's a structural disadvantage that shapes team total and run-line exposure for the week ahead. The birthday narrative sells tickets. The workload management sells the under.